Short Interest in Fortress Biotech, Inc. (NASDAQ:FBIOP) Grows By 144.4%

Fortress Biotech, Inc. (NASDAQ:FBIOP) was the target of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 2,200 shares, a growth of 144.4% from the September 15th total of 900 shares. Based on an average trading volume of 24,500 shares, the short-interest ratio is currently 0.1 days.

Fortress Biotech Stock Up 1.9 %

FBIOP stock opened at $5.14 on Friday. The business’s 50-day moving average price is $6.07 and its 200-day moving average price is $11.44. Fortress Biotech has a twelve month low of $4.86 and a twelve month high of $18.00.

About Fortress Biotech

Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.